Medicare Prescription Drug Savings and Choice Act of 2018
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jul 26, 2018)
Medicare Prescription Drug Savings and Choice Act of 2018
This bill requires the Centers for Medicare & Medicaid Services (CMS) to offer one or more Medicare-operated prescription drug plan options under the Medicare prescription drug benefit. In doing so, the CMS must: (1) negotiate prices with drug manufacturers; (2) establish an appeals process for denials of plan benefits, including the option for external review and determination by an independent entity; and (3) establish and apply a formulary and formulary incentives. In general, a Medicare-operated drug plan must meet the same requirements as apply to any other prescription drug plan.
What just happenedAug 13, 2018
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJul 26, 2018
- Aug 13, 2018Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 27, 2018Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 26, 2018IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jul 26, 2018IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jul 26, 2018IntroReferralIntro-H
Introduced in House
- Jul 26, 2018IntroReferral1000
Introduced in House